Evidence map›Paper›PMID 21439033›Full record

ArticleBMC medical genomics2011

2D-electrophoresis and multiplex immunoassay proteomic analysis of different body fluids and cellular components reveal known and novel markers for extended fasting.

Freek G Bouwman, Baukje de Roos, Isabel Rubio-Aliaga, L Katie Crosley, Susan J Duthie, Claus Mayer, Graham Horgan, Abigael C Polley, Carolin Heim, Susan L M Coort and 6 more

Open access · goldAbstract read
In one paragraph

Article in BMC medical genomics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Can ketone bodies inactivate coronavirus spike protein? The potential of biocidal agents against SARS-CoV-2.BioEssays : news and reviews in molecular, cellular and developmental biology · 2021
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Proteomics for systems toxicology.Computational and structural biotechnology journal · 2014
    Review
  9. Article
  10. Article
  11. Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis.American journal of respiratory and critical care medicine · 2012
    Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 3 countries.

Freek G BouwmanDepartment of Human Biology, NUTRIM, Maastricht University, Maastricht, The Netherlands.
Baukje de Roos
Isabel Rubio-Aliaga
L Katie Crosley
Susan J Duthie
Claus Mayer
Graham Horgan
Abigael C Polley
Carolin Heim
Susan L M Coort
Chris T Evelo
Francis Mulholland
Ian T Johnson
Ruan M Elliott
Hannelore Daniel
Edwin C M Mariman
Maastricht University · NLTechnical University of Munich · DEUniversity of Aberdeen · GBBiomathematics and Statistics Scotland · GBNorwich Research Park · GBQuadram Institute · GB

Funding

Biotechnology and Biological Sciences Research Council BBS/E/F/00042291
6 · The paper itself

Abstract

backgroundProteomic technologies applied for profiling human biofluids and blood cells are considered to reveal new biomarkers of exposure or provide insights into novel mechanisms of adaptation.

methodsBoth a non-targeted (classical 2D-electrophoresis combined with mass spectrometry) as well as a targeted proteomic approach (multiplex immunoassay) were applied to investigate how fasting for 36 h, as compared to 12 h, affects the proteome of platelets, peripheral blood mononuclear cells (PBMC), plasma, urine and saliva collected from ten healthy volunteers.

resultsBetween-subject variability was highest in the plasma proteome and lowest in the PBMC proteome. Random Forests analysis performed on the entire dataset revealed that changes in the level of the RhoGDI2 protein in PBMC and plasma ApoA4 levels were the two most obvious biomarkers of an extended fasting. Random Forests (RF) analysis of the multiplex immunoassay data revealed leptin and MMP-3 as biomarkers for extended fasting. However, high between-subject variability may have masked the extended fasting effects in the proteome of the biofluids and blood cells.

conclusionsIdentification of significantly changed proteins in biofluids and blood cells using a non-targeted approach, together with the outcome of targeted analysis revealed both known and novel markers for a 36 h fasting period, including the cellular proteins RhoGDI2 and CLIC1, and plasma proteins ApoA4, leptin and MMP-3. The PBMC proteome exhibited the lowest between-subject variability and therefore these cells appear to represent the best biosamples for biomarker discovery in human nutrigenomics.

Indexed as

FastingApolipoproteins ABiomarkersBlood CellsBody FluidsCluster AnalysisElectrophoresis, Gel, Two-DimensionalGuanine Nucleotide Dissociation InhibitorsHumansImmunoassayLeptinMass SpectrometryMatrix Metalloproteinase 3Principal Component AnalysisProteomeProteomicsapolipoprotein A-IVApolipoproteins AARHGDIB protein, humanBiomarkersGuanine Nucleotide Dissociation InhibitorsLeptinMatrix Metalloproteinase 3Proteomerho Guanine Nucleotide Dissociation Inhibitor betarho-Specific Guanine Nucleotide Dissociation InhibitorsTumor Suppressor Proteins

Identifiers

PMID21439033
PMCPMC3073865
OpenAlexW2118475500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.